UK Cystic Fibrosis Gene Therapy Consortium : Oxford …

Posted: Published on October 26th, 2015

This post was added by Dr P. Richardson

Welcome to the website of the Oxford University Gene Medicine Research Group. We are a University of Oxford research group based in the Radcliffe Department of Medicine at the John Radcliffe Hospital.

We are focused on the development of clinical gene therapies for the treatment of lung diseases. Our primary focus has been Cystic Fibrosis (CF) lung disease.

Together with colleagues at the University of Edinburgh and Imperial College London we form the UK Cystic Fibrosis Gene Therapy Consortium, funded by the Medical Research Council, the National Institute for Health Research and the UK Cystic Fibrosis Trust.

The Consortium is currently undertaking one of the world's largest ever gene therapy clinical trials in CF patients based on our gene therapy research.

Patient Recruitment for the Muti-Dose Clinical Trial

We are pleased to announce the launch of new charity Just Gene Therapy with the specific aim of raising funds for gene therapy research for CF. The charity has been established by Rosie Barnes in conjunction with Professor Eric Alton, and is the only way in which donations can directly support the work of the Consortium.

See the original post:
UK Cystic Fibrosis Gene Therapy Consortium : Oxford ...

Related Posts
This entry was posted in Gene Medicine. Bookmark the permalink.

Comments are closed.